Why is Bliss GVS Pharma falling/rising?

As of 11-Aug, Bliss GVS Pharma Ltd is currently priced at 173.30, reflecting a decrease of 3.6 points or 2.04%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 2.91%. Today's trading saw the stock touch an intraday low of Rs 172, indicating a downward trend. Despite a significant increase in delivery volume, which rose by 63.9% against the 5-day average, the stock's performance over the past week shows a decline of 3.64%. Although the stock has generated a robust return of 53.98% over the past year, its profits have decreased by 3.6%, suggesting that while the stock has performed well historically, recent profit declines may be impacting investor sentiment.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with a 1-week decline of 3.64% compared to the Sensex's smaller drop of 0.51%. This underperformance in the short term contrasts with the stock's strong long-term returns, where it has outperformed the BSE500 over various periods, including a 125.36% increase over three years. The company's low debt-to-equity ratio and fair valuation indicate stability, yet the current premium valuation compared to peers may be contributing to the stock's recent price decline. Overall, while the stock has shown resilience in the long term, the recent profit drop and short-term underperformance against the benchmark are likely influencing its current price movement.